Soluble zcytor 11 cytokine receptors
CA 2418950 A1 · Owner: Kindsvogel, Wayne R. · Inventors: Topouzis, Stavros; Kindsvogel, Wayne R.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Novel polypeptide combinations, polynucleotides encoding the polypeptides and , related compositions and methods are disclosed for soluble zcytor 11 receptors that may be used as novel cytokine antagonists and within methods for , detecting ligands that stimulate the proliferation and/or developemnt of hematopoietic, lymphoid and myeloid cells in vitro and in vivo. Ligand-binding receptor polypeptides and antibodies can also be used to block TIF activity in vitro and in vivo, and may be used in conjuction with TIF and other cytokines to selectively stimulate the immune system. The present invention also includes methods for producing the protein uses therefor and antibodies , thereto.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 8, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 8, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 8, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.